Citation: | Wu Changhong, Xu Ya'nan, Tian Qianchuan, et al. Research progress on basic immunology of organ transplantation in 2021[J]. ORGAN TRANSPLANTATION, 2022, 13(3): 317-324. doi: 10.3969/j.issn.1674-7445.2022.03.006 |
[1] |
OTSUKA S, MELIS N, GAIDA MM, et al. Calcineurin inhibitors suppress acute graft-versus-host disease via NFAT-independent inhibition of T cell receptor signaling[J]. J Clin Invest, 2021, 131(11): e147683. DOI: 10.1172/JCI147683.
|
[2] |
MOHAMMED MT, CAI S, HANSON BL, et al. Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation[J]. Am J Transplant, 2021, 21(5): 1893-1901. DOI: 10.1111/ajt.16484.
|
[3] |
GUGLIELMO C, BIN S, CANTARELLI C, et al. Erythropoietin reduces auto- and alloantibodies by inhibiting T follicular helper cell differentiation[J]. J Am Soc Nephrol, 2021, 32(10): 2542-2560. DOI: 10.1681/ASN.2021010098.
|
[4] |
MUÑOZ M, HEGAZY AN, BRUNNER TM, et al. Th2 cells lacking T-bet suppress naive and memory T cell responses via IL-10[J]. Proc Natl Acad Sci U S A, 2021, 118(6): e2002787118. DOI: 10.1073/pnas.2002787118.
|
[5] |
ROMANO M, TUNG SL, SMYTH LA, et al. Treg therapy in transplantation: a general overview[J]. Transpl Int, 2017, 30(8): 745-753. DOI: 10.1111/tri.12909.
|
[6] |
SCHWARZ C, MAHR B, MUCKENHUBER M, et al. In vivo Treg expansion under costimulation blockade targets early rejection and improves long-term outcome[J]. Am J Transplant, 2021, 21(11): 3765-3774. DOI: 10.1111/ajt.16724.
|
[7] |
ZHAO J, JIANG L, UEHARA M, et al. ACTH treatment promotes murine cardiac allograft acceptance[J]. JCI Insight, 2021, 6(13): e143385. DOI: 10.1172/jci.insight.143385.
|
[8] |
TREVELIN SC, ZAMPETAKI A, SAWYER G, et al. Nox2-deficient Tregs improve heart transplant outcomes via their increased graft recruitment and enhanced potency[J]. JCI Insight, 2021, 6(18): e149301. DOI: 10.1172/jci.insight.149301.
|
[9] |
HIRAI T, RAMOS TL, LIN PY, et al. Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance[J]. J Clin Invest, 2021, 131(8): e139991. DOI: 10.1172/JCI139991.
|
[10] |
SCHMITZ R, FITCH ZW, SCHRODER PM, et al. B cells in transplant tolerance and rejection: friends or foes?[J]. Transpl Int, 2020, 33(1): 30-40. DOI: 10.1111/tri.13549.
|
[11] |
ASANO Y, DACCACHE J, JAIN D, et al. Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection[J]. Nat Commun, 2021, 12(1): 4372. DOI: 10.1038/s41467-021-24615-6.
|
[12] |
ZENG F, CHEN Z, CHEN R, et al. Graft-derived extracellular vesicles transported across subcapsular sinus macrophages elicit B cell alloimmunity after transplantation[J]. Sci Transl Med, 2021, 13(585): eabb0122. DOI: 10.1126/scitranslmed.abb0122.
|
[13] |
WANG G, ZOU D, WANG Y, et al. IRF4 ablation in B cells abrogates allogeneic B cell responses and prevents chronic transplant rejection[J]. J Heart Lung Transplant, 2021, 40(10): 1122-1132. DOI: 10.1016/j.healun.2021.06.008.
|
[14] |
LI W, WANG D, YUE R, et al. Gut microbes enlarged the protective effect of transplanted regulatory B cells on rejection of cardiac allografts[J]. J Heart Lung Transplant, 2021, 40(12): 1502-1516. DOI: 10.1016/j.healun.2021.08.008.
|
[15] |
WANG B, ZHOU Q, LI A, et al. Preventing alloimmune rejection using circular RNA FSCN1-silenced dendritic cells in heart transplantation[J]. J Heart Lung Transplant, 2021, 40(7): 584-594. DOI: 10.1016/j.healun.2021.03.025.
|
[16] |
ZHAO J, QUE W, DU X, et al. Monotherapy with anti-CD70 antibody causes long-term mouse cardiac allograft acceptance with induction of tolerogenic dendritic cells[J]. Front Immunol, 2021, 11: 555996. DOI: 10.3389/fimmu.2020.555996.
|
[17] |
USUELLI V, BEN NASR M, D'ADDIO F, et al. MiR-21 antagonism reprograms macrophage metabolism and abrogates chronic allograft vasculopathy[J]. Am J Transplant, 2021, 21(10): 3280-3295. DOI: 10.1111/ajt.16581.
|
[18] |
LIN CM, GILL RG, MEHRAD B. The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation[J]. Am J Transplant, 2021, 21(11): 3550-3560. DOI: 10.1111/ajt.16690.
|
[19] |
ZHANG W, LI J, QI G, et al. Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy[J]. J Transl Med, 2018, 16(1): 19. DOI: 10.1186/s12967-018-1395-9.
|
[20] |
SCHEURER J, KITT K, HUBER HJ, et al. Graft-versus-host disease prevention by in vitro-generated myeloid-derived suppressor cells is exclusively mediated by the CD11b+CD11c+ MDSC subpopulation[J]. Front Immunol, 2021, 12: 754316. DOI: 10.3389/fimmu.2021.754316.
|
[21] |
LI J, TU G, ZHANG W, et al. CHBP induces stronger immunosuppressive CD127+ M-MDSC via erythropoietin receptor[J]. Cell Death Dis, 2021, 12(2): 177. DOI: 10.1038/s41419-021-03448-7.
|
[22] |
MARSHALL PL, NAGY N, KABER G, et al. Hyaluronan synthesis inhibition impairs antigen presentation and delays transplantation rejection[J]. Matrix Biol, 2021, 96: 69-86. DOI: 10.1016/j.matbio.2020.12.001.
|
[23] |
SCHMITZ R, FITCH ZW, SCHRODER PM, et al. C3 complement inhibition prevents antibody-mediated rejection and prolongs renal allograft survival in sensitized non-human primates[J]. Nat Commun, 2021, 12(1): 5456. DOI: 10.1038/s41467-021-25745-7.
|
[24] |
VAN DE WALLE I, SILENCE K, BUDDING K, et al. ARGX-117, a therapeutic complement inhibiting antibody targeting C2[J]. J Allergy Clin Immunol, 2021, 147(4): 1420-1429. DOI: 10.1016/j.jaci.2020.08.028.
|
[25] |
HERR F, DESTERKE C, BARGIEL K, et al. The proliferation of belatacept-resistant T cells requires early IFNα pathway activation[J]. Am J Transplant, 2022, 22(2): 489-503. DOI: 10.1111/ajt.16811.
|
[26] |
SUN H, HARTIGAN CR, CHEN CW, et al. TIGIT regulates apoptosis of risky memory T cell subsets implicated in belatacept-resistant rejection[J]. Am J Transplant, 2021, 21(10): 3256-3267. DOI: 10.1111/ajt.16571.
|
[27] |
TSAI HI, WU Y, LIU X, et al. Engineered small extracellular vesicles as a FGL1/PD-L1 dual-targeting delivery system for alleviating immune rejection[J]. Adv Sci (Weinh), 2022, 9(3): e2102634. DOI: 10.1002/advs.202102634.
|
[28] |
DENG C, JIN Q, WU Y, et al. Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection[J]. Drug Deliv, 2021, 28(1): 1759-1768. DOI: 10.1080/10717544.2021.1968978.
|
[29] |
SHI Y, LU Y, ZHU C, et al. Targeted regulation of lymphocytic ER stress response with an overall immunosuppression to alleviate allograft rejection[J]. Biomaterials, 2021, 272: 120757. DOI: 10.1016/j.biomaterials.2021.120757.
|
[30] |
PUIGMAL N, DOSTA P, SOLHJOU Z, et al. Microneedle-based local delivery of CCL22 and IL-2 enriches Treg homing to the skin allograft and enables temporal monitoring of immunotherapy efficacy[J]. Adv Funct Mater, 2021, 31(44): 2170324.
|
[31] |
LI Z, LIU R, GUO Z, et al. Celastrol-based nanomedicine promotes corneal allograft survival[J]. J Nanobiotechnology, 2021, 19(1): 341. DOI: 10.1186/s12951-021-01079-w.
|
[32] |
SIREN EMJ, LUO HD, TAM F, et al. Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers[J]. Nat Biomed Eng, 2021, 5(10): 1202-1216. DOI: 10.1038/s41551-021-00777-y.
|
[33] |
JOH S, NA HK, SON JG, et al. Quantitative analysis of immunosuppressive drugs using tungsten disulfide nanosheet-assisted laser desorption ionization mass spectrometry[J]. ACS Nano, 2021, 15(6): 10141-10152. DOI: 10.1021/acsnano.1c02016.
|
[34] |
GAO T, WU Y, WANG W, et al. Biomimetic glucan particles with aggregation-induced emission characteristics for noninvasive monitoring of transplant immune response[J]. ACS Nano, 2021, DOI: 10.1021/acsnano.1c03029[Epub ahead of print].
|
[35] |
SNYDER ME, FINLAYSON MO, CONNORS TJ, et al. Generation and persistence of human tissue-resident memory T cells in lung transplantation[J]. Sci Immunol, 2019, 4(33): eaav5581. DOI: 10.1126/sciimmunol.aav5581.
|
[36] |
PROSSER A, HUANG WH, LIU L, et al. Dynamic changes to tissue-resident immunity after MHC-matched and MHC-mismatched solid organ transplantation[J]. Cell Rep, 2021, 35(7): 109141. DOI: 10.1016/j.celrep.2021.109141.
|
[37] |
JIAO W, MARTINEZ M, ZUBER J, et al. PE-2: dynamic reconstitution of recipient resident memory T cell repertoire after human intestinal transplantation[J]. Transplantation, 2021, 105(7S): S29-S30. DOI: 10.1097/01.tp.0000757680.43181.b2.
|
[38] |
WEINER J, SVETLICKY N, KANG J, et al. CD69+ resident memory T cells are associated with graft-versus-host disease in intestinal transplantation[J]. Am J Transplant, 2021, 21(5): 1878-1892. DOI: 10.1111/ajt.16405.
|
[39] |
ABOU-DAYA KI, TIEU R, ZHAO D, et al. Resident memory T cells form during persistent antigen exposure leading to allograft rejection[J]. Sci Immunol, 2021, 6(57): eabc8122. DOI: 10.1126/sciimmunol.abc8122.
|
[40] |
TIAN Q, ZHANG Z, TAN L, et al. Skin and heart allograft rejection solely by long-lived alloreactive TRM cells in skin of severe combined immunodeficient mice[J]. Sci Adv, 2022, 8(4): eabk0270. DOI: 10.1126/sciadv.abk0270.
|